CryoLife, Inc. incorporated in 1984 in Florida, was the first biomedical company to specialize in the ultra-low temperature preservation of human heart valves used for cardiac reconstruction, primarily in children born with heart defects. The Company preserves and distributes human tissues and develops, manufactures, and commercializes medical devices for cardiac and vascular transplant applications. The human tissues distributed by CryoLife include the CryoValve® SG pulmonary human heart valve and the CryoPatch® SG pulmonary cardiac patch tissue, both processed using CryoLife’s proprietary SynerGraft® technology. CryoLife’s medical devices consist primarily of surgical adhesives, sealants, and hemostats including BioGlue® Surgical Adhesive, BioFoam® Surgical Matrix, PerClot®, which the Company began distributing for Starch Medical, Inc. in October 2010.
just a quick google found this. ill look into it more later at work now
- Forums
- ASX - By Stock
- AVR
- CardioCel on Wikipedia!!!!Superior product
CardioCel on Wikipedia!!!!Superior product, page-16
-
-
- There are more pages in this discussion • 86 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$12.65 |
Change
0.750(6.30%) |
Mkt cap ! $256.8M |
Open | High | Low | Value | Volume |
$12.00 | $12.82 | $12.00 | $324.0K | 26.30K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 946 | $12.39 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.70 | 250 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 367 | 12.820 |
2 | 211 | 12.770 |
1 | 1 | 12.650 |
1 | 180 | 12.590 |
1 | 180 | 12.340 |
Price($) | Vol. | No. |
---|---|---|
13.000 | 700 | 1 |
13.010 | 180 | 1 |
13.020 | 191 | 1 |
13.140 | 191 | 1 |
13.250 | 1149 | 2 |
Last trade - 11.42am 11/09/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |